Zenas BioPharma, Inc. Depreciation
Zenas BioPharma, Inc. (ZBIO) reported Depreciation of $10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- Zenas BioPharma, Inc. depreciation for the quarter ending 2026-06-30 was $4.00K, a 66.67% decline year-over-year.
- Zenas BioPharma, Inc. depreciation for the quarter ending 2026-03-31 was $6.00K, a 73.91% decline year-over-year.
- Zenas BioPharma, Inc. depreciation for the quarter ending 2025-12-31 was $10.00K, a 69.70% decline year-over-year.
- Zenas BioPharma, Inc. depreciation for the quarter ending 2025-09-30 was $11.00K, a 69.44% decline year-over-year.
- Zenas BioPharma, Inc. depreciation for fiscal 2025 was $56.00K, a 59.12% decline from fiscal 2024.
- Zenas BioPharma, Inc. depreciation for fiscal 2024 was $137.00K, a 21.24% increase from fiscal 2023.
- Zenas BioPharma, Inc. depreciation for fiscal 2023 was $113.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $10.00K 10-Q · filed 2026-08-13 | $20.00K derived: sum of 3 quarters · filed 2026-08-13 | $31.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-13 | $16.00K derived: sum of 2 quarters · filed 2026-05-13 | $27.00K derived: sum of 3 quarters · filed 2026-05-13 | $39.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $21.00K derived: sum of 2 quarters · filed 2026-03-16 | $33.00K derived: sum of 3 quarters · filed 2026-08-13 | $56.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $23.00K derived: sum of 2 quarters · filed 2026-08-13 | $46.00K 10-Q · filed 2025-11-12 | $79.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $35.00K 10-Q · filed 2026-08-13 | $68.00K derived: sum of 3 quarters · filed 2026-08-13 | $104.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $23.00K 10-Q · filed 2026-05-13 | $56.00K derived: sum of 2 quarters · filed 2026-05-13 | $92.00K derived: sum of 3 quarters · filed 2026-05-13 | $127.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $69.00K derived: sum of 2 quarters · filed 2026-03-16 | $104.00K derived: sum of 3 quarters · filed 2026-03-16 | $137.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $71.00K derived: sum of 2 quarters · filed 2025-11-12 | $104.00K 10-Q · filed 2025-11-12 | $134.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $68.00K 10-Q · filed 2025-08-12 | $98.00K derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | $33.00K 10-Q · filed 2025-05-15 | $63.00K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $113.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $83.00K 10-Q · filed 2024-11-12 |